Current methods used to investigate G protein coupled receptor oligomerisation

Journal of Pharmacological and Toxicological Methods

Volumn 54, Issue 1, 2006, Pages 26-35

  Harrison, Charlotte ^a   van der Graaf, Piet H ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Bioluminescence resonance energy transfer; Dimerisation; Fluorescence resonance energy transfer; G protein coupled receptor; Immunoprecipitation; Methods; Oligomerisation; Western blotting

Indexed keywords

ANTIBODY; DIMER; G PROTEIN COUPLED RECEPTOR; OLIGOMER;

ANTIBODY SPECIFICITY; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; BLEACHING; CELL DISRUPTION; ENERGY TRANSFER; FLUORESCENCE RESONANCE ENERGY TRANSFER; IMMUNOPRECIPITATION; INTERMETHOD COMPARISON; NONHUMAN; OLIGOMERIZATION; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; WESTERN BLOTTING;

ANIMALS; CHEMISTRY, ANALYTICAL; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; IMMUNOPRECIPITATION; LUMINESCENT PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

EID: 33745727129     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2005.11.001     Document Type: Article

References (56)

1. AbdAlla S., Lother H., el Massiery A., and Quitterer U. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Natural Medicines 7 (2001) 1003-1009
2. Agnati L.F., Ferre S., Lluis C., Franco R., and Fuxe K. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacological Reviews 55 (2003) 509-550
3. Ayoub M.A., Couturier C., Lucas-Meunier E., Angers S., Fossier P., Bouvier M., et al. Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. Journal of Biological Chemistry 277 (2002) 21522-21528
4. Ayoub M.A., Levoye A., Delagrange P., and Jockers R. Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers. Molecular Pharmacology 66 (2004) 312-321
5. Berglund M.M., Schober D.A., Esterman M.A., and Gehlert D.R. Neuropeptide Y Y4 receptor homodimers dissociate upon agonist stimulation. Journal of Pharmacology & Experimental Therapeutics 307 (2003) 1120-1126
6. Biebermann H., Krude H., Elsner A., Chubanov V., Gudermann T., and Gruters A. Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes 52 (2003) 2984-2988
7. Boute N., Jockers R., and Issad T. The use of resonance energy transfer in high-throughput screening: BRET versus FRET. Trends in Pharmacological Sciences 23 (2002) 351-354
8. Bulenger S., Marullo S., and Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends in Pharmacological Sciences 26 (2005) 131-137
9. Carrillo J.J., Lopez-Gimenez J.F., and Milligan G. Multiple interactions between transmembrane helices generate the oligomeric alpha1b-adrenoceptor. Molecular Pharmacology 66 (2004) 1123-1137
10. Carrillo J.J., Pediani J., and Milligan G. Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins. Journal of Biological Chemistry 278 (2003) 42578-42587
11. Chabre M., and le Maire M. Monomeric g-protein-coupled receptor as a functional unit. Biochemistry 44 (2005) 9395-9403
12. Cheng Z.J., and Miller L.J. Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. Journal of Biological Chemistry 276 (2001) 48040-48047
13. Cvejic S., and Devi L.A. Dimerization of the delta opioid receptor: Implication for a role in receptor internalization. Journal of Biological Chemistry 272 (1997) 26959-26964
14. Daly C.J., and McGrath J.C. Fluorescent ligands, antibodies, and proteins for the study of receptors. Pharmacology and Therapeutics 100 (2003) 101-118
15. Devi L.A. Heterodimerization of G-protein-coupled receptors: Pharmacology, signaling and trafficking. Trends in Pharmacological Sciences 22 (2001) 532-537
16. Devost D., and Zingg H.H. Identification of dimeric and oligomeric complexes of the human oxytocin receptor by co-immunoprecipitation and bioluminescence resonance energy transfer. Journal of Molecular Endocrinology 31 (2003) 461-471
17. Dinger M.C., Bader J.E., Kobor A.D., Kretzschmar A.K., and Beck-Sickinger A.G. Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells. Journal of Biological Chemistry 278 (2003) 10562-10571
18. Ferre S., Karcz-Kubicha M., Hope B.T., Popoli P., Burgueno J., Gutierrez M.A., et al. Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: Implications for striatal neuronal function. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 11940-11945
19. Fiorentini C., Gardoni F., Spano P., Di Luca M., and Missale C. Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-d-aspartate receptors. Journal of Biological Chemistry 278 (2003) 20196-201202
20. Floyd D.H., Geva A., Bruinsma S.P., Overton M.C., Blumer K.J., and Baranski T.J. C5a receptor oligomerization. II. Fluorescence resonance energy transfer studies of a human G protein-coupled receptor expressed in yeast. Journal of Biological Chemistry 278 (2003) 35354-35361
21. Gripentrog J.M., Kantele K.P., Jesaitis A.J., and Miettinen H.M. Experimental evidence for lack of homodimerization of the G protein-coupled human N-formyl peptide receptor. Journal of Immunology 171 (2003) 3187-3193
22. Hebert T.E., Moffett S., Morello J.P., Loisel T.P., Bichet D.G., Barret C., et al. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. Journal of Biological Chemistry 271 (1996) 16384-16392
23. Heding A. Use of the BRET 7TM receptor/beta-arrestin assay in drug discovery and screening. Expert Reviews in Molecular Diagnosis 4 (2004) 403-411
24. Hernanz-Falcon P., Rodriguez-Frade J.M., Serrano A., Juan D., del Sol A., Soriano S.F., et al. Identification of amino acid residues crucial for chemokine receptor dimerization. Nature Immunology 5 (2004) 216-223
25. Hoffmann C., Gaietta G., Bunemann M., Adams S.R., Oberdorff-Maass S., Behr B., et al. A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells. Nature Methods 2 (2005) 171-176
26. Jensen A.A., Hansen J.L., Sheikh S.P., and Brauner-Osborne H. Probing intermolecular protein-protein interactions in the calcium-sensing receptor homodimer using bioluminescence resonance energy transfer (BRET). European Journal of Biochemistry 269 (2002) 5076-5087
27. Jordan B.A., and Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399 (1999) 697-700
28. Kang D.S., Gustafsson C., Morgelin M., and Leeb-Lundberg L.M. B1 bradykinin receptor homo-oligomers in receptor cell surface expression and signaling: Effects of receptor fragments. Molecular Pharmacology 67 (2005) 309-318
29. Kuner R., Kohr G., Grunewald S., Eisenhardt G., Bach A., and Kornau H.C. Role of heteromer formation in GABAB receptor function. Science 283 (1999) 74-77
30. Latif R., Graves P., and Davies T.F. Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor. Journal of Biological Chemistry 277 (2002) 45059-45067
31. McVey M., Ramsay D., Kellett E., Rees S., Wilson S., Pope A.J., et al. Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human delta-opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. Journal of Biological Chemistry 276 (2001) 14092-14099
32. Mei G., Di Venere A., Rosato N., and Finazzi-Agro A. The importance of being dimeric. FEBS Journal 272 (2005) 16-27
33. Mellado M., Martinez A.C., and Rodriguez-Frade J.M. Analysis of G-protein-coupled receptor dimerization following chemokine signaling. Methods 27 (2002) 349-357
34. Mercier J.F., Salahpour A., Angers S., Breit A., and Bouvier M. Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. Journal of Biological Chemistry 277 (2002) 44925-44931
35. Milligan G. Applications of bioluminiscence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors. European Journal of Pharmaceutical Sciences 21 (2004) 397-405
36. Nemoto W., and Toh H. Prediction of interfaces for oligomerizations of G-protein coupled receptors. Proteins 58 (2005) 644-660
37. Ng G.Y., Clark J., Coulombe N., Ethier N., Hebert T.E., Sullivan R., et al. Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity. Journal of Biological Chemistry 274 (1999) 7607-7610
38. Ng G.Y., George S.R., Zastawny R.L., Caron M., Bouvier M., Dennis M., et al. Human serotonin1B receptor expression in Sf9 cells: Phosphorylation, palmitoylation, and adenylyl cyclase inhibition. Biochemistry 32 (1993) 11727-11733
39. Nimchinsky E.A., Hof P.R., Janssen W.G., Morrison J.H., and Schmauss C. Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells. Journal of Biological Chemistry 272 (1997) 29229-29237
40. Patel R.C., Lange D.C., and Patel Y.C. Photobleaching fluorescence resonance energy transfer reveals ligand-induced oligomer formation of human somatostatin receptor subtypes. Methods 27 (2002) 340-348
41. Percherancier Y., Berchiche Y.A., Slight I., Volkmer-Engert R., Tamamura H., Fujii N., et al. Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. Journal of Biological Chemistry 280 (2005) 9895-9903
42. Pfeiffer M., Kirscht S., Stumm R., Koch T., Wu D., Laugsch M., et al. Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization. Journal of Biological Chemistry 278 (2003) 51630-51637
43. Ramsay D., Carr I.C., Pediani J., Lopez-Gimenez J.F., Thurlow R., Fidock M., et al. High-affinity interactions between human alpha1A-adrenoceptor C-terminal splice variants produce homo-and heterodimers but do not generate the alpha1L-adrenoceptor. Molecular Pharmacology 66 (2004) 228-239
44. Ramsay D., Kellett E., McVey M., Rees S., and Milligan G. Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): Hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochemical Journal 365 (2002) 429-440
45. Rocheville M., Lange D.C., Kumar U., Patel S.C., Patel R.C., and Patel Y.C. Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity. Science 288 (2000) 154-157
46. Rocheville M., Lange D.C., Kumar U., Sasi R., Patel R.C., and Patel Y.C. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. Journal of Biological Chemistry 275 (2000) 7862-7869
47. Salim K., Fenton T., Bacha J., Urien-Rodriguez H., Bonnert T., Skynner H.A., et al. Oligomerization of G-protein-coupled receptors shown by selective co-immunoprecipitation. Journal of Biological Chemistry 277 (2002) 15482-15485
48. Siegel R.M., Chan F.K., Zacharias D.A., Swofford R., Holmes K.L., Tsien R.Y., et al. Measurement of molecular interactions in living cells by fluorescence resonance energy transfer between variants of the green fluorescent protein. Science STKE 38 (2000) 27
49. Stanasila L., Perez J.B., Vogel H., and Cotecchia S. Oligomerization of the alpha 1a-and alpha 1b-adrenergic receptor subtypes. Potential implications in receptor internalization. Journal of Biological Chemistry 278 (2003) 40239-40251
50. Terrillon S., Durroux T., Mouillac B., Breit A., Ayoub M.A., Taulan M., et al. Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Molecular Endocrinology 17 (2003) 677-691
51. van Rheenen J., Langeslag M., and Jalink K. Correcting confocal acquisition to optimize imaging of fluorescence resonance energy transfer by sensitized emission. Biophysical Journal 86 (2004) 2517-2529
52. Waldhoer M., Fong J., Jones R.M., Lunzer M.M., Sharma S.K., Kostenis E., et al. A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 9050-9055
53. Wang D., Sun X., Bohn L.M., and Sadee W. Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer. Molecular Pharmacology 67 (2005) 2173-2184
54. Wehrman T., Kleaveland B., Her J.H., Balint R.F., and Blau H.M. Protein-protein interactions monitored in mammalian cells via complementation of beta-lactamase enzyme fragments. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 3469-3474
55. White J.H., Wise A., Main M.J., Green A., Fraser N.J., Disney G.H., et al. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 396 (1998) 679-682
56. Xu J., He J., Castleberry A.M., Balasubramanian S., Lau A.G., and Hall R.A. Heterodimerization of alpha 2A- and beta 1-adrenergic receptors. Journal of Biological Chemistry 278 (2003) 10770-10777